Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
National Cancer Institute (NCI)
Scientific Title
A Phase 2 Study of Veliparib (ABT-888) and Local Irradiation, Followed by Maintenance Veliparib and Temozolomide, in Patients With Newly Diagnosed High-Grade Glioma (HGG) Without H3 K27M or BRAFV600 Mutations